Real-Time email alerts. Get critical information on your stocks.
1 Which stocks are you watching?
 2 Where to send your updates?

Illumina Inc. (ILMN) Stock Quote

Detailed Quote for Illumina Inc. (ILMN) 
$ 72.00   2.35 (+3.37%) Volume: 1.57 m 4:13 PM EDT May 17, 2013
After Hours:  $ 71.99   -0.01 (-0.01%) Volume: 6.44 k 5:22 PM EDT May 17, 2013
Today 5d 1m 3m 1y more
Last Price
72.00
Change $
2.35
Change %
3.37%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
70.13
High
72.42
Low
69.65
Prev Close
69.65
Last Trade
05/17/13
Volume
1.57 m
52 Wk Hi
77.11
52 Wk Low
37.77
Market Cap
8.96 b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
124,378,537
EPS (TTM)
0.75
PE Ratio
88.30
Exchange
NGS
News and Media for Illumina Inc.  (ILMN) 
Sector News | Topic News
News for ILMN
Thu, May 16, 2013
6:30 AM Illumina Launches BaseSpace\u00AE Apps - Business Wire
Wed, May 15, 2013
6:30 AM Illumina Announces Partnerships to Automate TruSeq\u00AE and Nextera\u00AE Sample Preparation Kits - Business Wire
Sat, May 11, 2013
8:00 AM Secrets to Making Money in LNKD, MCD, ILMN and FCX - Marketwired
Wed, May 01, 2013
6:30 AM Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May - Business Wire
Thu, Apr 25, 2013
4:05 PM Verinata Health Publishes Clinical Laboratory Performance Data for verifi\u00AE Prenatal Test - Business Wire
8:15 AM Free Research Reports on ARMH, ILMN, NFLX and TOL Issued by the Bedford Report - Marketwired
Mon, Apr 22, 2013
4:05 PM Illumina Reports Strong Start to Fiscal Year 2013 - Business Wire
4:05 PM Illumina Names Charles Dadswell as Senior Vice President and General Counsel - Business Wire
Thu, Apr 18, 2013
6:30 AM Illumina and Kindstar Global Announce Strategic Collaboration to Facilitate Clinical Adoption of Illumina Technologies in Asia - Business Wire
Mon, Apr 08, 2013
6:30 AM Illumina to Announce First Quarter 2013 Financial Results on Monday, April 22, 2013 - Business Wire
Thu, Apr 04, 2013
6:30 AM Illumina Launches TruSight(TM) Tumor Content Set - Business Wire
Wed, Mar 27, 2013
12:00 PM Illumina Technology Enables Findings of the Collaborative Oncological Gene-Environment Study (COGS) - Business Wire
Thu, Mar 21, 2013
4:28 PM Illumina Announces Favorable Outcome of Its Patent Litigation Against Life Technologies, Inc. - Business Wire
Thu, Mar 14, 2013
9:13 PM Illumina Announces Outcome of Its Patent Litigation Against Syntrix Biosystems, Inc. - Business Wire
Thu, Feb 21, 2013
4:05 PM Illumina Completes Acquisition of Verinata Health - Business Wire
Wed, Feb 20, 2013
6:30 AM Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference - Business Wire
Fri, Feb 15, 2013
8:00 AM Free Research Report on Sanofi, Steel Dynamics, Inc., NextEra Energy, Inc., Illumina, Inc. and GNC Holdings, Inc. - Marketwired
Tue, Jan 08, 2013
8:45 AM Free Research Reports on BIOL, CELG, ILMN and HAR Issued by the Bedford Report - Marketwired
8:00 AM The Real Story Behind ARCT, ILMN, KEY and GLW - Marketwired
Wed, Dec 19, 2012
8:00 AM Should Recent Insider Selling on FAST, MXIM, ILMN and WRE Matter to You? - Marketwired
More News for ILMN >>

Tags for Illumina Inc.

Research stocks or mutual funds related to Illumina Inc. by keywords or tags. Find companies that have a similar focus to ILMN. The keywords below have been associated to ILMN by either user submission or electronic means.

dna microarray data dna microarray microarray software customer retention microarray applications gene expression profiling microarray suite protein microarray slides expression profiling dna array pharmaceutical training microarray chips microarray database dna diagnostic custom microarray microarrays customer satisfaction solutions improve customer service expression data analysis gene expression analysis customer relationships microarray company microrna microarray promoter microarray pharmaceutical sales microarray protocol protein microarray customer analytics pharma dna analysis pharmaceutical sales rep antibody microarray pharmaceutical consultant biotech Drugs microarray dna analysis protein array dna chip microarray service regulatory affairs cdna microarray customer churn customer service product microarray scanner pharmaceutical consulting pharmaceutical industry microarray slides microarray bioinformatics microarray technology proteomic software

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.